Post-hoc analysis revealed that h-TERC mRNA levels in the patients with IPF tended to be higher compared with those in the control subjects (p=0.08) (Table IVB, Fig. 2). This evidence concerns the gene TERC and idiopathic pulmonary fibrosis.